Trawicki joins Zoetis from GE Healthcare and brings more than 20 years of experience in healthcare manufacturing and operations to the role
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Roman Trawicki
as President of its Global Manufacturing and Supply organization.
With more than 20 years of broad, international experience in healthcare
manufacturing and operations, Mr. Trawicki will oversee the company’s
global manufacturing and supply network that produces more than 300
animal health product lines for the company. As the world leader in
animal health, Zoetis utilizes a network of 27 internal manufacturing
facilities and about 200 external suppliers to manufacture and deliver
its products to veterinarians and livestock producers in more than 120
countries.
Mr. Trawicki will join Zoetis from GE Healthcare, where he has been
General Manager of Global Supply Chain for Medical Diagnostics focusing
on diagnostics, injectable contrast media and nuclear medicines. In that
role, he has managed 2,500 colleagues across the world and overseen 16
manufacturing sites. During his career he has gained extensive global
leadership experience in lean manufacturing, supply and operations from
additional roles at GE Healthcare, Coloplast and Smith & Nephew.
“I am confident that Zoetis will benefit from Roman’s experience and
leadership, along with his manufacturing, operations, and continuous
improvement expertise,” said Kristin Peck, Executive Vice President and
Group President for Zoetis, with responsibility for manufacturing and
supply. “He brings an outside perspective that will strengthen our
manufacturing organization and serve us well as we capitalize on
advances inside and outside of Zoetis to optimize our network for the
future. As always, our collective goal remains to deliver high quality,
reliable supply at competitive costs, and drive profitable results for
Zoetis.”
Mr. Trawicki earned his bachelor’s degree in Mechanical Engineering from
University of Hertfordshire, U.K. in 1986, and worked in engineering
roles for Ford Motor Company, Black & Decker Corporation and Cummins
Engine Company before moving into the healthcare sector at Smith &
Nephew in 1992.
Mr. Trawicki will join the company on January 1, 2015, replacing Carolyn
Hawver, current president of the Global Manufacturing and Supply
organization. Ms. Hawver had announced her retirement plans earlier in
the year, and the appointment of Mr. Trawicki completes that leadership
transition. He will be based at the company’s location in Zaventem,
Belgium, and report to Ms. Peck.
About Zoetis
Zoetis
(zô-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more than 60
years of experience in animal health, Zoetis discovers, develops,
manufactures and markets veterinary vaccines and medicines, complemented
by diagnostic products and genetic tests and supported by a range of
services. In 2013, the company generated annual revenue of $4.6 billion.
With approximately 9,800 employees worldwide at the beginning of 2014,
Zoetis has a local presence in approximately 70 countries, including 27
manufacturing facilities in 10 countries. Its products serve
veterinarians, livestock producers and people who raise and care for
farm and companion animals in 120 countries. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect the
current views of Zoetis with respect to business plans or prospects,
future operating or financial performance, expectations regarding
products, future use of cash and dividend payments, and other future
events. These statements are not guarantees of future performance or
actions. Forward-looking statements are subject to risks and
uncertainties. If one or more of these risks or uncertainties
materialize, or if management's underlying assumptions prove to be
incorrect, actual results may differ materially from those contemplated
by a forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. A
further list and description of risks, uncertainties and other matters
can be found in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2013, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future Results”
and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and
in our Current Reports on Form 8-K. These filings and subsequent filings
are available online at www.sec.gov,
www.zoetis.com,
or on request from Zoetis.
Media Contacts:
Bill Price, 1-973-443-2742 (o)
william.price@zoetis.com
or
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Investor Contact:
John O'Connor, 1-973-822-7088 (o)
john.oconnor@zoetis.com